{
  "trial_id": "NCT01780974",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Montreal Cognitive Assessment score, Clinical Dementia Rating, systolic blood pressure, diastolic blood pressure, antihypertensive medication status, lipid-lowering medication status, Omega-3 index, Geriatric Depression Scale score, general health status, screening laboratory values, English language proficiency, history of cancer, liver disease status, history of ventricular fibrillation or ventricular tachycardia, psychiatric disorder status, central nervous system disease status, diabetes status, fish intake frequency, Omega-3 fatty acid supplement intake, Lipoic Acid supplementation status, medication use (systemic corticosteroids, neuroleptics, antiparkinsonian agents, narcotic analgesics), MRI contraindications, enrollment in other treatment studies.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Systolic BP",
          "systolic blood pressure"
        ],
        [
          "Diastolic BP",
          "diastolic blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Education",
        "Apo E4 Carrier",
        "Exercise",
        "Smoking",
        "Arachidonic Acid (AA)",
        "Eicosapentaenoic Acid (EPA)",
        "Docosahexaenoic Acid (DHA)"
      ],
      "remaining_candidate_features": [
        "Montreal Cognitive Assessment score",
        "Clinical Dementia Rating",
        "antihypertensive medication status",
        "lipid-lowering medication status",
        "Omega-3 index",
        "Geriatric Depression Scale score",
        "general health status",
        "screening laboratory values",
        "English language proficiency",
        "history of cancer",
        "liver disease status",
        "history of ventricular fibrillation or ventricular tachycardia",
        "psychiatric disorder status",
        "central nervous system disease status",
        "diabetes status",
        "fish intake frequency",
        "Omega-3 fatty acid supplement intake",
        "Lipoic Acid supplementation status",
        "medication use (systemic corticosteroids, neuroleptics, antiparkinsonian agents, narcotic analgesics)",
        "MRI contraindications",
        "enrollment in other treatment studies"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Montreal Cognitive Assessment Score, Clinical Dementia Rating, Systolic Blood Pressure, Diastolic Blood Pressure, Omega-3 Index, Geriatric Depression Scale, Use of Antihypertensive Medication, Use of Lipid Lowering Medication,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Systolic BP",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic BP",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Education",
        "Apo E4 Carrier",
        "Exercise",
        "Smoking",
        "Arachidonic Acid (AA)",
        "Eicosapentaenoic Acid (EPA)",
        "Docosahexaenoic Acid (DHA)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Montreal Cognitive Assessment Score",
        "Clinical Dementia Rating",
        "Omega-3 Index",
        "Geriatric Depression Scale",
        "Use of Antihypertensive Medication",
        "Use of Lipid Lowering Medication"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Hypertension Diagnosis Duration, Systolic Blood Pressure, Diastolic Blood Pressure, Omega-3 Index, Geriatric Depression Scale, Montreal Cognitive Assessment, Clinical Dementia Rating, Body Mass Index, Lipid Profile.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Systolic BP",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic BP",
          "Diastolic Blood Pressure"
        ],
        [
          "Eicosapentaenoic Acid (EPA)",
          "Omega-3 Index"
        ],
        [
          "Docosahexaenoic Acid (DHA)",
          "Omega-3 Index"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Education",
        "Apo E4 Carrier",
        "Exercise",
        "Smoking",
        "Arachidonic Acid (AA)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Hypertension Diagnosis Duration",
        "Geriatric Depression Scale",
        "Montreal Cognitive Assessment",
        "Clinical Dementia Rating",
        "Body Mass Index",
        "Lipid Profile"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, education level, Montreal Cognitive Assessment score, Clinical Dementia Rating, systolic blood pressure, diastolic blood pressure, antihypertensive medication use, lipid lowering medication use, Omega-3 index, Geriatric Depression Scale score, body mass index, smoking status, medical history (including hypertension, diabetes, cancer, liver disease, psychiatric disorders, central nervous system diseases), medication use (including corticosteroids, neuroleptics, antiparkinsonian agents, narcotic analgesics), MRI eligibility.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Education",
          "education level"
        ],
        [
          "Systolic BP",
          "systolic blood pressure"
        ],
        [
          "Diastolic BP",
          "diastolic blood pressure"
        ],
        [
          "Eicosapentaenoic Acid (EPA)",
          "Omega-3 index"
        ],
        [
          "Docosahexaenoic Acid (DHA)",
          "Omega-3 index"
        ],
        [
          "Smoking",
          "smoking status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Apo E4 Carrier",
        "Exercise",
        "Arachidonic Acid (AA)"
      ],
      "remaining_candidate_features": [
        "Montreal Cognitive Assessment score",
        "Clinical Dementia Rating",
        "antihypertensive medication use",
        "lipid lowering medication use",
        "Geriatric Depression Scale score",
        "body mass index",
        "medical history (including hypertension, diabetes, cancer, liver disease, psychiatric disorders, central nervous system diseases)",
        "medication use (including corticosteroids, neuroleptics, antiparkinsonian agents, narcotic analgesics)",
        "MRI eligibility"
      ]
    }
  }
}